Walking and cognition, but not symptoms, correlate with dual task cost of walking in multiple sclerosis

- Performing a cognitive task while walking results in a reduction in walking performance among persons with MS.
- Very little is known about correlates of the dual task cost (DTC) of walking in MS.
- The identification of correlates is important for designing interventions that reduce the DTC of walking.
- This paper indicates that walking performance might be a target of interventions for reducing the DTC of walking in MS.

BackgroundPerforming a cognitive task while walking results in a reduction of walking performance among persons with MS. To date, very little is known about correlates of this dual task cost (DTC) of walking in MS.PurposeWe examined walking performance, cognitive processing speed, and symptoms of fatigue, depression, anxiety, and pain as correlates of DTC of walking in MS.Methods82 persons with MS undertook a 6-min walk test (6MWT) and completed the Symbol Digit Modalities Test (SDMT), Fatigue Severity Scale (FSS), Short-form of the McGill Pain Questionnaire (SF-MPQ), Hospital Anxiety and Depression Scale (HADS), and self-reported Expanded Disability Status Scale (SR-EDSS). The participants completed 4 trials of walking at a self-selected pace on an electronic walkway that recorded spatiotemporal parameters of gait. The first 2 trials were performed without a cognitive task, whereas the second 2 trials were completed while performing a modified Word List Generation task.ResultsThere were significant and large declines in gait performance with the addition of a cognitive task for velocity (p < .001, η2 = .52), cadence (p < .001, η2 = .49), and step length (p < .001, η2 = .23). 6MWT and SDMT scores correlated with DTC for velocity (r = −.41, p < .001 and r = −.32, p < .001, respectively) and step length (r = −.45, p < .001 and r = −.37, p < .001, respectively); there were no significant associations between FSS, SF-MPQ, and HADS scores with the DTC of walking. Regression analyses indicated that 6MW, but not SDMT, explained variance in DTC for velocity (ΔR2 = .11, p < .001) and step length (ΔR2 = .13, p < .001), after controlling for SR-EDSS scores.ConclusionWalking performance might be a target of interventions for reducing the DTC of walking in MS.